GWPH News and Press, GW Pharmaceuticals Plc From 02/06/21

On Wednesday, Jazz Pharmaceuticals (JAZZ) said it would acquire GW Pharma (GWPH) in a $7.2B deal.Acquisition gives Jazz access to GW's cannibinoid drug for seizures, Epidiolex, as well as other cannibinoid-based therapies in the pipeline.Several other biopharmas are exploring cannibinoid trea...

Pot investors are hardly strangers to splashy mergers and acquisitions. And following the big news about Aphria and Tilray combining their companies , there's a new deal that's making waves in the cannabis sector. On Wednesday, Jazz Pharmaceuticals (NASDAQ: JAZZ) announc...

Jazz made a bold bet with the acquisition of GW Pharmaceuticals. The deal brings a potential blockbuster Epidiolex and a nascent cannabinoid-based pipeline. Jazz's dependence on Xyrem should reduce substantially. Increased debt is a potential risk. For further details se...

Jazz Pharmaceuticals (NASDAQ: JAZZ) was out of tune with the biotech investment community -- not to mention its own shareholders -- for much of last year. Indeed, its stock has lagged behind the S&P 500 , with an annual return of 6.8% compared to the index's 18...

Editors Note: This story is reprinted with permission from Streetwise Reports. Biopharmaceutical firm GW Pharmaceuticals Plc (GWPH:NASDAQ) , which utilizes its proprietary cannabinoid product platform to develop and commercialize new medicines across a broad range of disea...

Cannabis Stocks Heating Up In February Top marijuana stocks are a hot sector to begin in February with some reaching new highs in the market. With the growth of the cannabis industry both medicinally and for recreational use, pot stocks are gaining value. Currently, leaders in the U...

Cannabis stocks could see new highs this year. Fueling momentum, Jazz Pharmaceuticals (NASDAQ:JAZZ) said it would acquire GW Pharmaceuticals (NASDAQ:GWPH) to help strengthen its neuroscience business with GWPH’s cannabis-based epilepsy treatment. That also set in motion stren...

Listen on the go! A daily podcast of Wall Street Breakfast will be available by 8:00 a.m. on Seeking Alpha, iTunes, Stitcher and Spotify. Going big on stimulusThe Biden administration is moving full speed ahead on a $1.9T coronavirus economic relief plan after House Democrats adopted a budget...

Are These The Best Biotech Stocks To Buy Now? 4 Names To Know Biotech stocks have been on fire in the last few months. The reason being how some of these companies delivered on investor expectations by announcing breakthrough clinical results or introduced revolutionary medicine...

Jazz Pharmaceuticals (JAZZ) raised to overweight from neutral at Piper Sandler after announcing agreement to acquire GW Pharmaceuticals (GWPH). JAZZ down 2%.``Epidiolex is the kind of durable asset that renders the potential erosion of the oxybate franchise as less problematic, positioni...